Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting

PDF  |  How to cite

Oncotarget. 2018; 9:26977-26977. https://doi.org/10.18632/oncotarget.25604

Metrics: PDF 1280 views  |   ?  

Ji-Young Kim1,*, Ji-Hae Han1,*, Geon Park2, Young-Woo Seo3, Cheol-Won Yun4, Byung-Chul Lee5, Jeehyeon Bae6, Ae Ran Moon1,* and Tae-Hyoung Kim1,*

1Department of Biochemistry, Chosun University School of Medicine, Dong-Gu, Gwang-Ju, Korea
2Department of Laboratory Medicine, Chosun University School of Medicine, Dong-Gu, Gwang-Ju, Korea
3Korea Basic Science Institute Gwang-Ju Center, Chonnam National University, Buk-Gu, Gwang-Ju, Korea
4School of Life Science and Biotechnology, Korea University, Seoul, Korea
5Geno ux. Co., Ltd., Sejong City, Korea
6School of Pharmacy, Chung-Ang University, Dongjak-Gu, Seoul, Korea
*These authors equally contributed to this work

Published: June 01, 2018

This article has been corrected: The correct Grant Support information is given below:


This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant no. 2010-0009201 and NRF-2013R1A1A2058254 to TH Kim), by the Ministry of Science, ICT, and Future Planning (NRF-2014R1A2A1A11050442 to TH Kim), and by the National R&D Program for Cancer Control funded by the Ministry of Health and Welfare of the Korean government (Grant no. HI14C2025 to TH Kim).

Original article: Oncotarget. 2016; 7:32449-32461. DOI: https://doi.org/10.18632/oncotarget.8719.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25604